Alan Cooke serves as Sebela Pharmaceutical’s Chief Executive Officer and President. Prior to joining Sebela Pharmaceuticals, Mr. Cooke held a number of executive level positions primarily in pharmaceuticals and medical devices including Chief Financial Officer and subsequently Chief Executive Officer of Trulife Group Limited; Chief Financial Officer and subsequently President and Chief Operating Officer of Amarin Corporation, plc; and Vice President, Global Strategic Planning of Elan Corporation, plc. Mr. Cooke is a fellow of the Institute of Chartered Accountants (Ireland) having qualified with KPMG in 1994. Mr. Cooke also currently serves as Chairman of the Board of the Institute of Neuroscience at Trinity College Dublin and as a Director of DS Biopharma Limited.
Alan Cooke serves as Sebela Pharmaceutical’s Chief Executive Officer and President. Prior to joining Sebela Pharmaceuticals, Mr. Cooke held a number of executive level positions primarily in pharmaceuticals and medical devices including Chief Financial Officer and subsequently Chief Executive Officer of Trulife Group Limited; Chief Financial Officer and subsequently President and Chief Operating Officer of Amarin Corporation, plc; and Vice President, Global Strategic Planning of Elan Corporation, plc. Mr. Cooke is a fellow of the Institute of Chartered Accountants (Ireland) having qualified with KPMG in 1994. Mr. Cooke also currently serves as Chairman of the Board of the Institute of Neuroscience at Trinity College Dublin and as a Director of DS Biopharma Limited.